Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated statements of changes in convertible preferred shares and shareholders' (deficit) equity

v3.24.0.1
Consolidated statements of changes in convertible preferred shares and shareholders' (deficit) equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020 50,657,042        
Beginning balance at Dec. 31, 2020 $ 135,810        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Conversion of Convertible Preferred Shares to Ordinary Shares (in shares) (50,657,042)        
Conversion of Convertible Preferred Shares to Ordinary Shares upon IPO $ (135,810)        
Ending balance (in shares) at Dec. 31, 2021 0        
Ending balance at Dec. 31, 2021 $ 0        
Beginning balance (in shares) at Dec. 31, 2020   15,326,281      
Beginning balance at Dec. 31, 2020 (145,060) $ 42 $ 25,908 $ 76 $ (171,086)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of Convertible Preferred Shares to Ordinary Shares upon IPO (in shares)   50,657,042      
Conversion of Convertible Preferred Shares to Ordinary Shares upon IPO 135,810 $ 136 135,674    
Issuance of shares in relation to initial public offering, net of issuance costs (in shares)   7,550,531      
Issuance of ordinary shares under the employee share purchase plan 150,666 $ 23 150,643    
Exercise of stock options and vesting of RSUs (in shares)   1,311,587      
Exercise of stock options and vesting of RSUs 1,222 $ 4 1,218    
Share-based compensation 11,171   11,171    
Other comprehensive income (loss) 84     84  
Net loss (68,979)       (68,979)
Ending balance (in shares) at Dec. 31, 2021   74,845,441      
Ending balance at Dec. 31, 2021 $ 84,914 $ 205 324,614 160 (240,065)
Ending balance (in shares) at Dec. 31, 2022 0        
Ending balance at Dec. 31, 2022 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of shares in relation to initial public offering, net of issuance costs (in shares)   357,508      
Issuance of ordinary shares under the employee share purchase plan 2,083 $ 1 2,082    
Exercise of stock options and vesting of RSUs (in shares)   1,230,823      
Exercise of stock options and vesting of RSUs 2,034 $ 4 2,030    
Share-based compensation 16,987   16,987    
Deferred costs in relation to initial public offering 121   121    
Other comprehensive income (loss) (527)     (527)  
Net loss $ (83,661)       (83,661)
Ending balance (in shares) at Dec. 31, 2022 76,433,772 76,433,772      
Ending balance at Dec. 31, 2022 $ 21,951 $ 210 345,834 (367) (323,726)
Ending balance (in shares) at Dec. 31, 2023 0        
Ending balance at Dec. 31, 2023 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of shares in relation to initial public offering, net of issuance costs (in shares)   293,208      
Issuance of ordinary shares under the employee share purchase plan 1,259 $ 1 1,258    
Exercise of stock options and vesting of RSUs (in shares)   1,923,898      
Exercise of stock options and vesting of RSUs 2,307 $ 5 2,302    
Share-based compensation 18,164   18,164    
Other comprehensive income (loss) 1,239     1,239  
Net loss $ (29,373)       (29,373)
Ending balance (in shares) at Dec. 31, 2023 78,650,878 78,650,878      
Ending balance at Dec. 31, 2023 $ 15,547 $ 216 $ 367,558 $ 872 $ (353,099)